This paper derives a distinct object of analysis that has not previously appeared in aging, cancer, or prion disease research: the drug target interaction topology of a combined anti-aging and prion prophylaxis protocol, expressed as a seven-node intervention graph (I1–I7) with explicitly mapped antagonistic edges, redundant subgraphs, conditional dependencies, and a defined equilibrium target state. The seven intervention nodes are: I1 (telomere maintenance), I2 (Identity Anchor agonism), I3 (aging drift gene silencing), I4 (mTOR inhibition / rapamycin axis), I5 (PRNP-ASO substrate reduction), I6 (PrP conformation stabilisation / anle138b), and I7 (cancer surveillance / synthetic SSDD). Four antagonistic couplings are identified and precisely resolved. Coupling 1 (I1 -> cancer): telomere maintenance activates the same telomerase pathway used by 90% of cancers; resolved by sequencing I7 before I1. Coupling 2 (I4 -| I7): chronic mTOR inhibition suppresses immune surveillance; resolved by pulsed rapamycin scheduling with I5 covering the autophagy gap. Coupling 3 (I5 -| neuroprotection): PrPC substrate reduction simultaneously removes the normal copper-binding, NMDA-modulating, and antioxidant functions of PrPC; resolved by 50-60% partial dosing plus I6 synergy, with the long-term dissolution achieved by G127V base editing (Synthetic Fore Strategy). Coupling 4 (I2 -> genomic instability in transition-zone cells): Identity Anchor agonism in Hub-locked cells creates transcriptional conflict; resolved by mandatory Hub inhibitor co-administration. Cross-species validation shows that natural selection has already produced three distinct viable solutions to this coupling topology: the naked mole rat (I7 structural via HMM-HA + I1 telomere + I4 proteostasis, all constitutively active — the recommended human template), the bowhead whale (I7 DNA repair + I1 + I4), and the elephant (maximum I7 via TP53×20 + minimal I1, trading regenerative capacity for zero cancer). The Fore people's G127V evolution is identified as a Coupling 3 dissolution event that removed the I5 neuroprotective trade-off permanently from their lineage. The equilibrium Waddington landscape is defined as the state in which every major false attractor formation pathway (cancer, prion, neurodegeneration, aging drift) is covered by at least two redundant intervention nodes, no single node creates an uncovered risk, and all antagonistic edges are mitigated by scheduling or dose titration. Six novel claims are locked with timestamp 2026-03-09 and each is assigned a named falsifying experiment.
Eric Robert Lawson (Mon,) studied this question.